- Home
- NBIX vs ULS Comparison
NBIX vs ULS Comparison
Compare NBIX & ULS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- ULS
- Stock Information
- Founded
- NBIX 1992
- ULS 1894
- Country
- NBIX United States
- ULS United States
- Employees
- NBIX N/A
- ULS N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- ULS
- Sector
- NBIX Health Care
- ULS
- Exchange
- NBIX Nasdaq
- ULS Nasdaq
- Market Cap
- NBIX 14.4B
- ULS 15.8B
- IPO Year
- NBIX 1996
- ULS 2024
- Fundamental
- Price
- NBIX $154.77
- ULS $85.60
- Analyst Decision
- NBIX Strong Buy
- ULS Hold
- Analyst Count
- NBIX 18
- ULS 8
- Target Price
- NBIX $172.06
- ULS $78.75
- AVG Volume (30 Days)
- NBIX 1.0M
- ULS 589.6K
- Earning Date
- NBIX 10-28-2025
- ULS 11-04-2025
- Dividend Yield
- NBIX N/A
- ULS 0.61%
- EPS Growth
- NBIX 12.44
- ULS 10.58
- EPS
- NBIX 4.19
- ULS 1.67
- Revenue
- NBIX $2,682,700,000.00
- ULS $3,003,000,000.00
- Revenue This Year
- NBIX $23.68
- ULS $6.79
- Revenue Next Year
- NBIX $18.02
- ULS $6.23
- P/E Ratio
- NBIX $36.93
- ULS $51.18
- Revenue Growth
- NBIX 19.61
- ULS 6.68
- 52 Week Low
- NBIX $84.23
- ULS $48.54
- 52 Week High
- NBIX $157.67
- ULS $91.95
- Technical
- Relative Strength Index (RSI)
- NBIX 67.44
- ULS 70.34
- Support Level
- NBIX $133.62
- ULS $76.84
- Resistance Level
- NBIX $157.67
- ULS $91.95
- Average True Range (ATR)
- NBIX 4.47
- ULS 2.35
- MACD
- NBIX 1.07
- ULS 0.50
- Stochastic Oscillator
- NBIX 87.92
- ULS 61.77
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About ULS UL Solutions Inc.
UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.